Johnson & Johnson sued Samsung Bioepis for allegedly breaching a contract agreement over its launch of a biosimilar to ...

J&J said it is seeking a preliminary injunction for Samsung Bioepis' Stelara biosimilar over an unauthorized sublicense deal ...

Certified Biobased Product label, confirming it as 100% bio-based last year. Starting with prototype production, the company plans to actively promote the product to sustainability-driven companies in ...

As biosimilar versions of a big-selling Johnson & Johnson medicine reach the U.S. market, the health care giant accused one ...

By choosing Knauf Insulation glasswool and other products free from Red List materials, you are helping to create a materials ...

BridgeBio beat investor expectations with 1,028 unique prescriptions for ATTR-CM therapy Attruby, setting the company up to ...

Innovation in sugar-free emulsions catering to diabetic and health-conscious consumers: Fact.MRRockville, March 04, 2025 (GLOBE NEWSWIRE) -- The global beverage emulsions industry has an estimated ...

Johnson & Johnson on Monday filed a lawsuit against Samsung Bioepis in a New Jersey federal court, accusing the Korean ...

Q4 2024 Earnings Conference Call February 27, 2025 4:30 PM ETCompany ParticipantsYvonne Briggs - Alliance Advisors IRDr.

Resilience, innovation and reinvention: the sustainable bond market in 2025 While overall market growth remains elusive, ...